- Home
- KNSA vs BAK Comparison
KNSA vs BAK Comparison
Compare KNSA & BAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNSA
- BAK
- Stock Information
- Founded
- KNSA 2015
- BAK 1972
- Country
- KNSA United Kingdom
- BAK Brazil
- Employees
- KNSA N/A
- BAK N/A
- Industry
- KNSA Biotechnology: Pharmaceutical Preparations
- BAK Major Chemicals
- Sector
- KNSA Health Care
- BAK Industrials
- Exchange
- KNSA Nasdaq
- BAK Nasdaq
- Market Cap
- KNSA 1.7B
- BAK 1.7B
- IPO Year
- KNSA 2018
- BAK N/A
- Fundamental
- Price
- KNSA $20.59
- BAK $4.00
- Analyst Decision
- KNSA Strong Buy
- BAK Strong Buy
- Analyst Count
- KNSA 5
- BAK 3
- Target Price
- KNSA $36.60
- BAK $9.75
- AVG Volume (30 Days)
- KNSA 290.2K
- BAK 1.3M
- Earning Date
- KNSA 10-29-2024
- BAK 11-06-2024
- Dividend Yield
- KNSA N/A
- BAK N/A
- EPS Growth
- KNSA N/A
- BAK N/A
- EPS
- KNSA N/A
- BAK N/A
- Revenue
- KNSA $384,098,000.00
- BAK $13,764,416,401.00
- Revenue This Year
- KNSA $60.05
- BAK $14.26
- Revenue Next Year
- KNSA $36.32
- BAK $8.26
- P/E Ratio
- KNSA N/A
- BAK N/A
- Revenue Growth
- KNSA 54.41
- BAK 2.86
- 52 Week Low
- KNSA $16.56
- BAK $3.93
- 52 Week High
- KNSA $28.15
- BAK $10.98
- Technical
- Relative Strength Index (RSI)
- KNSA 40.95
- BAK 26.09
- Support Level
- KNSA $19.97
- BAK $3.93
- Resistance Level
- KNSA $20.85
- BAK $4.35
- Average True Range (ATR)
- KNSA 0.69
- BAK 0.22
- MACD
- KNSA 0.03
- BAK -0.06
- Stochastic Oscillator
- KNSA 35.61
- BAK 5.62
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
About BAK Braskem SA ADR
Braskem SA manufactures and sells chemicals, petrochemicals, fuels, and utilities. The company's geographical segments include Brazil; the United States and Europe and Mexico. It derives a majority of its revenue from Brazil. It produces olefins, such as ethylene, polymer and chemical-grade propylene, butadiene, and butene-1; fuels, such as automotive gasoline, liquefied petroleum gas, or LPG, ethyl tertiary-butyl ether, or ETBE, and methyl tertiary-butyl ether, or MTBE; intermediates, such as cumene and others.